Get started

Please fill in the form below and an Ezra representative will contact you within 1 business day.

Notify me

Please fill in the form below and we will be in touch when we launch in your city.

Blog / Prostate Health

What is Prostate Adenocarcinoma?

Oct. 24 2019 by Sheherzad Raza Preisler Blog Editor, PR, & Social Media Coordinator
What is Prostate Adenocarcinoma?

The prostate is a small gland found in the groin responsible for supplying the body with seminal fluid, which helps sperm travel and survive on its journey towards fertilizing eggs. Of course, cancer can develop in the prostate, though it’s typically asymptomatic in its early stages. There are, though, a handful of signs that could potentially mean you have prostate cancer, such as:

  • Trouble urinating
  • The urge to urinate often, especially at night
  • Blood in the urine or semen
  • Loss of bladder or bowel control
  • Erectile dysfunction
  • Pain in the chest, hips, or back

The above can also be signs of other conditions as well, however. It’s important to speak to a healthcare provider about what it is you’re experiencing so you can get to the root of the issue as soon as possible. 

It’s important to catch prostate cancer early, because if you catch it while it’s still confined to the prostate or nearby organs, the chances you will survive at least five years is almost 100%. And there are a number of risk factors that may increase your likelihood of developing the disease; if you fit into one or more of these categories, it’s likely your doctor will suggest you be more vigilant in your routine prostate cancer screening. 

If you’re diagnosed with prostate cancer, your disease will be graded upon a Gleason score. The system is used to evaluate the likely aggressiveness of your cancer. The number is a sum of two separate scores whose total ranges from 1-10. The higher the score, the more likely the tumor is to grow quickly and metastasize, or spread throughout the body. 

The most common type of prostate cancer is prostate adenocarcinoma; adenocarcinomas develop in gland cells. This prostate cancer subtype is considered the second leading cause of cancer-related mortalities in men. It’s common in older folks, and its incidence rises with age, with 70% of those diagnosed with the disease age 70 or above.

The Ezra approach uses MRI, as opposed to the industry-standard PSA blood test to look for evidence of prostate cancer. A 2012 review showed that PSA tests are only approximately 21% accurate, while a 2017 study showed that MRI technology is about 92% accurate in screening for prostate cancer. 

In addition to our prostate scans, our torso and full-body scans also screen the prostate for signs of cancer. If you’d like to learn more about our pricing plans, you may to do here.